Federico Piscione, MD

Endovascular Treatment of Residual Type A Aortic Dissection Preserving Patency of Supra-Aortic Vessels by Implantation of the Djumbodis System. No More Surgery for the Aortic Arch?

10/26/2011

Gabriele Iannelli , MD;

Federico Piscione , MD;

Plinio Cirillo , MD, PhD;

ABSTRACT: A persistent distal false lumen perfusion—residual type A aortic dissection—is found in 50% to 100% of patients following ascending aorta replacement. Complications of persistent or newly developed dissection of the distal aorta are...

ABSTRACT: A persistent distal...

10/26/2011

Journal of Invasive Cardiology

Steroid-Eluting Stents in Patients with ACS. Angiographic Results of DESIRE: Dexamethasone-Eluting Stent Italian REgistry

03/04/2009

Leonardo Paloscia , MD;

Nicoletta De Cesare , MD;

Federico Piscione , MD;

Francesca Vassanelli , MD;

Corrado Tamburino , MD, PhD, FESC, FSCAI;

Fabrizio Tomai , MD;

Gabriele Pesarini , MD, PhD;

Flavio Ribichini , MD;

Valeria Ferrero , MD;

From the aDepartment of Biomedical Sciences and Surgery of the Università di Verona, Verona, the bEuropean Hospital, Rome, the cOspedale Santo Spirito, Pescara, the dPoliclinico San Marco, Zingonia, the eUniversità di Catania, Ospedale...

From the aDepartment of...

03/04/2009

Journal of Invasive Cardiology

Original Contribution

Unrestricted Use of Endeavor Resolute Zotarolimus-Eluting Stent in Daily Clinical Practice: A Prospective Registry

05/29/2012

Domenico Sirico , MD;

Chiara De Biase , MD;

Tullio Niglio , MD;

Federico Piscione , MD;

Gennaro Galasso , MD;

Raffaele Piccolo , MD;

Salvatore Cassese , MD;

Giovanni Esposito , MD;

Plinio Cirillo , MD, PhD;

Dario Leosco , MD;

Antonio Rapacciuolo , MD;

Abstract: Background. To evaluate the safety and efficacy of unrestricted Endeavor Resolute zotarolimus-eluting stent (ZES) use. Furthermore, we sought to evaluate clinical outcomes associated with on- and off-label use of Resolute ZES....

Abstract: Background. To...

05/29/2012

Journal of Invasive Cardiology